Biovac starts trials on South Africa's first domestically developed cholera vaccine

South African Medical Research Council head Prof Glenda Grey administers a cholera vaccine to Shadrack Makutu, a participant in the clinical trials for the vaccine developed by Biovac at the Chris Hani Baragwanath Hospital in Soweto, South Africa, Tuesday, Nov. 11, 2025. (AP Photo/ Alfonso Nqunjana)

JOHANNESBURG (AP) — Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

The oral , developed by the Cape Town-based pharmaceutical firm Biovac, is currently undergoing trials to determine its safety in adults and will be followed by trials to compare it to existing cholera vaccines that are already in the market.

The ɫtv Press. All rights reserved.

More Science Stories

Sign Up to Newsletters

Get the latest from ɫtvNews in your inbox. Select the emails you're interested in below.